Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_assertion type Assertion NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_head.
- NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_assertion description "[Juvenile Myelomonocytic Leukemia (JMML) is a relentlessly progressive myeloproliferative/myelodysplastic (MPD/MDS) hematopoietic disorder more common in patients with any one of at least three distinct genetic lesions, specifically NF1 gene loss and PTPN11 and NRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_provenance.
- NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_assertion evidence source_evidence_literature NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_provenance.
- NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_assertion SIO_000772 21681782 NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_provenance.
- NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_assertion wasDerivedFrom befree-2016 NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_provenance.
- NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_assertion wasGeneratedBy ECO_0000203 NP902822.RA4nrYXLOVSZxBCAoxgtQyubCS5bobIqTYhVDq1iff6VA130_provenance.